Here are commemorative photos from our event. Thank you to all the speakers and participants for making our 2018 Immunogenicity and Tolerance seminar a successful one! We will see you next year!
This seminar will center around current translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.
To date, the committee has confirmed the attendance of the following speakers:
Tom Ottenhoff, MD, PhD (Leiden University Medical Center)
New vaccination and therapeutic strategies against bacterial infectious diseases
Rene Raeven, PhD (Intravacc)
Effect of vaccine composition and immunization route on induction of innate immune responses and adaptive immunity against Bordetella pertussis
Rebecca Ashfield, PhD (Oxford University)
RH5: a candidate vaccine for blood stage P falciparum malaria
Andrew Godkin, MD (Institute of Infection and Immunity, School of Medicine, Cardiff University)
The role of the oncofetal antigen 5T4-specific CD4+ T cells in colorectal cancer
Vibha Jawa, PhD (Merck)
Mechanisms behind immune response to minor impurities and their ability to break tolerance
Naomi Benne, MSc (Leiden Academic Centre for Drug Research)
Anionic 1,2-Distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice
Willem van Eden, MD, PhD (Utrecht University)
Tolerogenic Dendritic cells as therapy for Rheumatoid Arthritis
You may view the full conference program here.
Interested in attending this seminar? Please register for the event here.
This is a not-for-profit event. All registration and sponsorship fees will be allocated to the cost of hosting the seminar.
A special thank you to our
Gold sponsor: 
Gold sponsor:
Gold sponsor:
Silver sponsor:
For more information, please contact Sarah Moniz at [email protected].
